Bizarre Patents
Safety System For Remove a Rider From a Vehicle by Deploying a Parachute
Methods and apparatus for reducing the velocity of a rider in or on an open cockpit vehicle when the rider is thrown from the vehicle.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8097754 | Synthesis of (S)-(+)-3-(aminomethyl)-5-methyl hexanoic acid Provided are syntheses of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid, (S)-Pregabalin via a chiral intermediate of the following formula 4 wherein Ar is a C6-10 aromatic group, R is a straight or branched C | 01/17/2012 |
| 7777073 | Topical delivery system for antiaging and skin whitening agents This invention relates to certain hydroxyaryl alkanols, alkyl amines, alkyl amino acids, alkyl amino esters, and alkyl amino alkanols (“Hydroxyaryl compounds”) of formula (I). A method of topical application of said hydroxyaryl compounds is also disclosed. The t... | 08/17/2010 |
| 7772426 | Method for producing L-2-amino-4-(hydroxymethylphosphinyl)-butanoic acid Disclosed is a method for efficiently and highly selectively producing L-2-amino-4-(hydroxymethylphosphinyl)-butanoic acid, which is useful as a herbicide, through a catalytic asymmetric synthesis reaction. Specifically disclosed is a method for producing L-2-amino-... | 08/10/2010 |
| 7750181 | Antiproliferative agents This invention relates to certain dioxodihydropyridine derivatives and certain methacrylic acid and furan derivative precursors thereof, processes for their preparation, pharmaceutical compositions containing such compounds and their use as anti-proliferative agents... | 07/06/2010 |
| 7423172 | Tyrosine derivatives as PPAR-γ-modulators Compounds of general formula I, and the salts and solvates thereof, wherein R1 represents the radical 2-benzoylphenylamino; R2 represents —(CH2)s—N(COR3)-A-J-T or —(CH2)s—N(R4)—B-J-T; and s.... | 09/09/2008 |
| 7388105 | Compounds and use to reduce the formation of malodour Malodour formation reducing compounds alpha-N-(3-Methyl-5-phenylpentanoxycarbonyl)-L-glutamine, alpha-N-(2-Methyl-5-phenylpentanoxycarbonyl)-L-glutamine, and alpha-N-(2,4-Dimethyl-4-phenylbutanoxycarbonyl)-L-glutamine, and their salts, compositions comprising such c... | 06/17/2008 |
| 7342127 | Substituted anilide ligands for the thyroid receptor Novel thyroid receptor ligands are provided having the general formula I wherein X, R1, R2, R3, R4, R5, R6, R7,... | 03/11/2008 |
| 7329777 | Methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis This invention relates to methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis, comprising administering an effective amount of a compound of formula (I) in which the several varia... | 02/12/2008 |
| 7282605 | Optically active 2-allylcarboxylic acid derivative and process for producing the same The present invention provides a process for producing an optically active 2-allylcarboxylic acid derivative, which is useful as a pharmaceutical intermediate, from readily available and inexpensive starting materials by the process which can be practiced on a comme... | 10/16/2007 |
| 7238830 | N-alkylaspartyl dipeptide ester compounds The present invention provides N-alkylaspartyl dipeptideester compounds and salts thereof, such as N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester, which provide high degrees of sweetness in comparison to conventional... | 07/03/2007 |
| 7208631 | 2-alkylcysteinamide or salt thereof, process for producing these, and use of these A process for producing a 2-alkylcysteinamide, which comprises hydrolysis of a 4-alkylthiazolidine-4-carboxamide represented by the general formula (2) or a salt thereof: wherein R represents a lower alkyl group ... | 04/24/2007 |
| 7202381 | Compounds as opioid receptor modulators This invention is directed towards novel compounds as opioid receptor modulators, antagonists, and agonists useful for the treatment of opioid modulated disorders such as pain and gastrointestinal disorders. ... | 04/10/2007 |
| 7153822 | Compositions and methods for modulating connexin hemichannels Disclosed are compositions and methods for modulating hemichannel function in a cell, tissue or organ. The invention also relates to useful screens for detecting such compounds, particularly those capable of modulating connexin phosphorylation. Further provided are ... | 12/26/2006 |
| 7153997 | Benzamide derivatives as thyroid receptor ligands This invention relates to novel compounds, which are thyroid receptor ligands, and to methods of preparing such compounds. In addition, a method is provided for preventing, inhibiting or treating diseases or disorders associated with metabolism dysfunction or which ... | 12/26/2006 |
| 7091373 | Production method for biarylalanine There is provided a production method for producing a biarylalanine compound of formula (4): wherein R1 represents a amino protective group and R2 represents an amino protective group or a h... | 08/15/2006 |
| 7067694 | Halogen-substituted amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases Compounds of the general formula (I) wherein R1 represents halogen, R2 and R3 represent H or halogen, and R4 represents C3-8-cycloalkyl or optionally substituted p... | 06/27/2006 |
| 7064229 | Succinic acid derivatives The present invention relates to compounds of the general formula (I), processes for their preparation, pharmaceutical compositions containing them as well as their use for the production of pharmaceutical compositions for the treatment of inflammatory diseases ... | 06/20/2006 |
| 7057066 | Process for producing 3-amino-2-hydroxypropionic acid derivatives The present invention provides a process for preparing 3-amino-2-hydroxypropionic acid derivatives (1) which does not use dangerous reagents, is economically advantageous, and is suitable for an industrial production, which process comprises: ... | 06/06/2006 |
| 7049342 | Substituted phenylpropionic acid derivatives The invention provides novel substituted phenylpropionic acid derivatives that bind to the receptor as ligands of human peroxisome proliferator-activated receptor α (PPARα) to activate and exhibit potent lipid-decreasing action, and processes for preparing them. | 05/23/2006 |
| 7030268 | Methods for producing acylphenylalanine There is provided a method for producing easily highly-purified acylphenylalanine that is useful as a raw material of pharmaceutical products and the like, which comprises the step of reacting an acid chloride with phenylalanine in a mixed solvent of an organic solv... | 04/18/2006 |
| 7026490 | Amorphous organic 1,3,2-dioxaborine luminophores, method for the production and use thereof The invention relates to luminophores having semiconducting properties and to the production and use thereof in organic luminous diodes (OLEDS) and organic solar cells. The novel materials are easy to prepare and exhibit excellent current density and efficiency when... | 04/11/2006 |
| 6939989 | Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases Compounds of the general formula (I) wherein R1 represents halogen, R2 represent H or halogen, and R3 represents C3-8-cycloalkyl, C3-8-cycloalkenyl, or optionally ... | 09/06/2005 |
| 6939515 | Apparatuses and methods for creating and testing pre-formulations and systems for same The invention provides methods, apparatus, and systems for performing high-throughput preparation and screening of salts and polymorphs of drug candidates. The invention is directed towards enhancing the pre-formulation discovery process used for drug development. I... | 09/06/2005 |
| 6936597 | Prodrugs of anticancer agents employing substituted aromatic acids Polymeric prodrugs of the formula: wherein B is selected from the group consisting of OH, leaving groups, residues of amine-containing moieties and a residues of hydroxyl-containing m... | 08/30/2005 |
| 6921774 | Compounds and their use as glycine transport inhibitors The invention provides novel compounds of the formula I below: wherein the meaning of each substituent is defined in the application. The compounds are useful as inhibitors of the glycine transporter and useful in the ... | 07/26/2005 |
| 6780998 | Substituted 2-aminoalkyl-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same The oxidation hair dye precursor composition contains from 0.005 to 20.0 percent by weight of one or more coupler compounds and from 0.005 to 20.0 percent by weight of one or more developer compounds. The one or more developer compounds include at least one substitu... | 08/24/2004 |
| 6759551 | Chiral (s- or r-methylphenylglycine) amino acid crystal and method for preparing same The invention concerns chiral amino acid, is preparation method, and the use of said chiral amino acid as intermediate for the synthesis of chiral organic compounds. ... | 07/06/2004 |
| 6710071 | Difluoromethylene aromatic ethers as inhibitors of glycine transport This invention relates to a series of difluoromethylene aromatic ethers of the formula wherein ring A and X and Y are defined as in the specification, that exhibit activity as glycine transport inhibitors, their pharmace... | 03/23/2004 |
| 6696487 | Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives The invention relates to compounds of formula (I), and also to salts thereof, which have fungicidal activities: ##STR1## in which the various radicals and substituents are as defined in the description, and also to the fungicidal compositions containing t... | 02/24/2004 |
| 6646157 | Method for making HBED The preparation of a mono-cationic salt of N,N'-bis(2-hydroxybenzyl)-ethylenediamine-N,N'-diacetic acid (HBED) and HBED itself is disclosed. In particular, the invention relates to the hydrolysis of the t-butyl ester of HBED with a weak acid, such as form... | 11/11/2003 |
| 6632830 | ACE-2 inhibiting compounds and methods of use thereof ACE-2 inhibiting compounds are disclosed. These compounds include compounds of formula (IV): ##STR1## wherein the variables are as described in the specification. Pharmaceutical compositions containing the compounds are also discussed. The pharmaceut... | 10/14/2003 |
| 6627771 | Gamma amino butyric and acid analogs The instant invention is improved gamma amino butyric acid analogs, processes for their preparation, and methods of using them as agents for treating epilepsy and other neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disor... | 09/30/2003 |
| 6624152 | Cell adhesion inhibitors The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of us... | 09/23/2003 |
| 6610855 | Synthesis of 3-amino-3-aryl propanoates A process for the synthesis of a compound of the formula ##STR1## wherein R1 is aryl, heteroaryl, substituted aryl or substituted heteroaryl and R2 is hydrogen, alkyl or aralkyl, or salt thereof.... | 08/26/2003 |
| 6603043 | Process for the preparation of (schiff bases of) -alkyl--amino acid amides Process for the preparation of a Schiff base of an -alkyl--amino acid amide and an aldehyde, wherein the corresponding -aminonitrile is contacted with a base and the aldehyde and wherein it is ensured that the reagents are in good con... | 08/05/2003 |
| 6579987 | Diaryl-enynes Provided, among other things, is a compound of Formula I: ##STR1## wherein: Ar1 and Ar2 are independently selected aryl groups, optionally substituted with up to five substituents independently selected from the group consisting of a... | 06/17/2003 |
| 6566550 | Substituted aromatic ethers as inhibitors of glycine transport This invention relates to a series of substituted aromatic ethers of the formula I ##STR1## wherein ring A and X and Y are defined as in the specification, that exhibit activity as glycine transport inhibitors, their pharmaceutically acceptable salts... | 05/20/2003 |
| 6562967 | Kinetic resolutions of chiral 2-and-3-substituted carboxylic acids One aspect of the present invention relates to a method for the kinetic resolution of racemic and diastereomeric mixtures of chiral compounds. The critical elements of the method are: a non-racemic chiral tertiary-amine-containing catalyst; a racemic or d... | 05/13/2003 |
| 6541644 | Isolation of natural L-ଲ-3-indolylalanine and enrichment of natural aliphatic amino acid mixtures with natural L-ଲ-3-indolylalanine Processes for isolating substantially pure natural L-ଲ-3-indolylalanine (L-ଲ-3) from a mixture of amino acids, such as a protein hydrolysate. A protein hydrolysate, for example of casein or soy protein, is passed over a polymeric resin attract... | 04/01/2003 |
| 6528685 | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives Novel derivatives of 1-aminoindan and their salts are described. Optically active 1-aminoindan derivatives are prepared by reacting a N-benzyl analog of the desired compound with an enantiomer of mandelic acid. Parkinson's disease, dementia, epilepsy, con... | 03/04/2003 |
